Natural Product: NPC159720

Natural Product IDNPC159720
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
IIWKLAHNKXXKAJ-WAABAYLZSA-N
IUPAC Name n.a.
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier n.a.
PubChem CID 46186857
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0001392] Lignans, neolignans and related compounds
      • [CHEMONTID:0001844] Flavonolignans

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey IIWKLAHNKXXKAJ-WAABAYLZSA-N
Standard InCHI InChI=1S/C25H22O10/c1-32-16-4-2-11(6-14(16)28)24-20(10-26)33-18-7-12(3-5-17(18)34-24)25-23(31)22(30)21-15(29)8-13(27)9-19(21)35-25/h2-9,20,23-29,31H,10H2,1H3/t20-,23-,24-,25+/m0/s1
SMILES COc1ccc(cc1O)[C@H]1[C@H](CO)Oc2cc(ccc2O1)[C@@H]1[C@H](C(=O)c2c(cc(cc2O1)O)O)O

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   482.12 Volume:   459.711
?
Van der Waals volume.
Dense:   1.049 LogP:   1.926
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   2.099
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -4.036
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   4.0 Rigid Bonds:   29.0
TPSA:   155.14
?
Topological Polar Surface Area.
H-Bond Acceptor:   10.0
H-Bond Donor:   5.0 Rings:   5.0
Heavy Atoms:   10.0

MedChem Properties

QED Drug-Likeness Score:   0.374 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   4.006 Fsp3:   0.24
MCE-18:   97.742
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Rejected BMS Rule:   1
Chelating Alert:   1 PAINS Alert:   0
Colloidal aggregators:   0.833 Fluc inhibitor:   0.547
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.056
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.565
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.38 Promiscuous compounds:   0.344

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -6.477 MDCK Permeability:   -5.27
Pgp-inhibitor:   0.994 Pgp-substrate:   0.105
PAMPA:   0.055
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.003
20% Bioavailability (F20%):   0.003 30% Bioavailability (F30%):   0.959
50% Bioavailability (F50%):   0.992

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.012 MRP1:   0.762
Plasma Protein Binding (PPB):   95.464% Volume Distribution (VD):   0.036
Fu: 3.94%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   1.0
OATP1B3 inhibitor:   1.0 BCRP inhibitor:   0.976
BSEP inhibitor:   0.962

ADMET: Metabolism

CYP1A2-inhibitor:   0.806 CYP1A2-substrate:   0.0
CYP2C19-inhibitor:   0.0 CYP2C19-substrate:   0.004
CYP2C9-inhibitor:   0.199 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.013 CYP2D6-substrate:   0.614
CYP3A4-inhibitor:   0.151 CYP3A4-substrate:   0.911
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.942
HLM stability:   0.009
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  4.035 Half-life (T1/2):  2.411

ADMET: Toxicity

hERG Blockers:  0.121 hERG Blockers (10um):  0.366
Human Hepatotoxicity (H-HT):  0.925 Drug-induced Liver Injury (DILI):  0.921
AMES Toxicity:  0.78 Rat Oral Acute Toxicity:  0.55
Maximum Recommended Daily Dose:  0.289 Skin Sensitization:  0.996
Carcinogencity:  0.405 Eye Corrosion:  0.0
Eye Irritation:  0.848 Respiratory Toxicity:  0.564
Drug-induced Neurotoxicity:  0.397 Ototoxicity:  0.634
Hematotoxicity:  0.44 Drug-induced Nephrotoxicity:  0.92
Genotoxicity:  0.978 RPMI-8226 Immunitoxicity:  0.324
A549 Cytotoxicity:  0.907 Hek293 Cytotoxicity:  0.811
BCF:   0.877
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   3.542
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   5.058
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   4.218
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO5645 Silybum marianum Species Asteraceae Eukaryota n.a. n.a. n.a. DOI[10.1080/10496475.2013.791908]
NPO5645 Silybum marianum Species Asteraceae Eukaryota n.a. whole plant n.a. PMID[16394559]
NPO5645 Silybum marianum Species Asteraceae Eukaryota n.a. n.a. n.a. PMID[24456525]
NPO5645 Silybum marianum Species Asteraceae Eukaryota Seeds n.a. n.a. PMID[24597776]
NPO5645 Silybum marianum Species Asteraceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO5645 Silybum marianum Species Asteraceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO5645 Silybum marianum Species Asteraceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO5645 Silybum marianum Species Asteraceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO5645 Silybum marianum Species Asteraceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO5645 Silybum marianum Species Asteraceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC159720 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.8286 Intermediate Similarity NPC138688
0.8286 Intermediate Similarity NPC72787
0.8286 Intermediate Similarity NPC217795
0.8286 Intermediate Similarity NPC58223
0.7887 Intermediate Similarity NPC36916
0.7887 Intermediate Similarity NPC36
0.7887 Intermediate Similarity NPC7154
0.7887 Intermediate Similarity NPC125039
0.7887 Intermediate Similarity NPC7688
0.746 Intermediate Similarity NPC320825
0.6232 Remote Similarity NPC326037
0.6232 Remote Similarity NPC13858
0.6119 Remote Similarity NPC250922
0.597 Remote Similarity NPC44721
0.597 Remote Similarity NPC211466
0.597 Remote Similarity NPC605332
0.5882 Remote Similarity NPC36835
0.5882 Remote Similarity NPC246162
0.5882 Remote Similarity NPC9743
0.5882 Remote Similarity NPC260491
0.5882 Remote Similarity NPC61506
0.5882 Remote Similarity NPC240476
0.5714 Remote Similarity NPC471515
0.5588 Remote Similarity NPC19721
0.5522 Remote Similarity NPC21835
0.5441 Remote Similarity NPC62290
0.5441 Remote Similarity NPC142731
0.5441 Remote Similarity NPC326506
0.5441 Remote Similarity NPC4152
0.5357 Remote Similarity NPC279209
0.5357 Remote Similarity NPC102277
0.5357 Remote Similarity NPC479117
0.5294 Remote Similarity NPC75827
0.5139 Remote Similarity NPC302950
0.506 Remote Similarity NPC606364

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC159720 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.7887 Intermediate Similarity NPD6166 Phase 2
0.7887 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7887 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.5139 Remote Similarity NPD1934 Phase 0

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data